Profile Details

Contact

★★★★★

☆☆☆☆☆

USD 100 /hr

★★★★★

☆☆☆☆☆

Hire Dr. M. Bilal F.

Switzerland

USD 100 /hr

Experienced Scientist | Neurodegeneration

Profile Summary

Experience and track record in leading scientific research projects, managing collaborations within and across international scientific teams, and coordinating research efforts with prominent pharmaceutical companies and contract research organizations, towards: (i) the establishment of innovative models of neurodegeneration, (ii) dissecting molecular mechanisms underlying neuropathology, and (iii), establishing medium-throughput assays for the identification of therapeutic modifiers of neurotoxicity.

Subject Matter Expertise

• ★ Neuroscience
• ☆ Biotechnology & Bioengineering

Services

• Writing

Writing Clinical Trial Documentation, Technical Writing

Work Experience

Co-Founder and Director fo R&D

ND-BioSciences

September 2019 - Present

Post-doctoral Fellow / Study Director

Philip Morris International (PMI) R&D, Switzerland

March 2017 - August 2019

Education

Ph.D. in Biotechnology and Bioengineering, Focus: Neuroscience

École Polytechnique Fédérale de Lausanne

September 2010 - August 2015

Master of Science (M.S.) in Biology

American University of Beirut

September 2008 - August 2010

Bachelor of Science (B.S.) in Biology

Lebanese University

September 2004 - August 2008

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

(2018). N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting . Journal of Biological Chemistry.

(2016). Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson’s disease . Proceedings of the National Academy of Sciences.

(2015). Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, andin Vivo . Journal of Biological Chemistry.

(2015). Anti-Inflammatory and Cytostatic Activities of a Parthenolide-Like Sesquiterpene Lactone fromCota palaestinasubsp.syriaca . Evidence-Based Complementary and Alternative Medicine.

(2014). The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of  -synuclein, and enhances its secretion and nuclear localization in cells . Human Molecular Genetics.

(2013). Context dependent reversion of tumor phenotype by connexin-43 expression in MDA-MB231 cells and MCF-7 cells: Role of β-catenin/connexin43 association . Experimental Cell Research.

(2012). Characterization of Semisynthetic and NaturallyNα-Acetylated α-Synucleinin Vitroand in Intact Cells . Journal of Biological Chemistry.

(2012). α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, andEscherichia coliExists Predominantly as Disordered Monomer . Journal of Biological Chemistry.